COVID-19 News, COVERAGE—OTHER AGENCY DOCUMENTS: Experimental monoclonal antibody treatment for Alzheimer’s may be covered by Medicare for trial enrollees, (Jan 12, 2022)

By Leah S. Poniatowski, J.D.

CMS seek comments for proposed coverage determination and will announce decision in April.

CMS published a National Coverage Determination (NCD) proposing Medicare coverage for those enrolled in FDA-approved clinical trials of monoclonal antibody treatment targeting amyloid in patients with Alzheimer’s disea ...